Why Are Many Women Considering Zofran Lawsuits?

by Terry Bryant

Many women who have used Zofran are involved in lawsuits throughout the U.S., and for good reason. GlaxoSmithKline, the drug’s creator, has been recklessly aggressive in marketing ondansetron, the medication’s trade name, in situations in which it has not been approved. And the company’s deceptive pursuit of increased profits has resulted in a frightening number of serious side effects, most of them inflicted on the most vulnerable.

Ondansetron was approved by the FDA in 1991 for patients dealing with postsurgical nausea or vomiting, or nausea caused by chemotherapy. It has never been approved for additional uses, but GlaxoSmithKline pushed and paid doctors into prescribing it for off-label use in women suffering from morning sickness. Recent studies, however, have demonstrated a substantially increased risk of birth defects, such as heart malformations or skull deformities, in children exposed to ondansetron during gestation. Most troubling, court documents show that GlaxoSmithKline may have been aware of these risks as far back as 1992. However, they continued pushing for its use knowing that it would cause undue harm to a lot of unborn children.

As a result of the devastating side effects, Zofran lawsuits have involved extremely high judgments, and the company has been staggered by a $3 billion judgment levied against it. Part of this judgment is a fine for committing fraud and deceptive marketing, but much of it will be disbursed to families badly harmed by GlaxoSmithKline’s shameful recklessness.